Premium
Soluble expression of human DRR1 (down‐regulated in renal cell carcinoma 1) in Escherichia coli and preparation of its polyclonal antibodies
Author(s) -
Zhao XinYu,
Li HongXia,
Liang ShuFang,
Yuan Zhu,
Yan Fei,
Ruan XuZhi,
You Jia,
Xiong ShaoQuan,
Tang MingHai,
Wei YuQuan
Publication year - 2008
Publication title -
biotechnology and applied biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 70
eISSN - 1470-8744
pISSN - 0885-4513
DOI - 10.1042/ba20070027
Subject(s) - polyclonal antibodies , recombinant dna , microbiology and biotechnology , escherichia coli , molecular mass , fusion protein , antibody , biology , affinity chromatography , expression vector , immunohistochemistry , biochemistry , chemistry , gene , enzyme , immunology
Human DRR1 (down‐regulated in renal cell carcinoma 1) is widely expressed in normal tissues but dramatically reduced or even undetectable in a number of different cancer cell lines and primary tumour types. DRR1 from Homo sapiens was cloned into the pQE30 vector for fusion‐protein expression with six histidine residues in Escherichia coli BL21(DE3). A soluble protein with a molecular mass of approx. 19 kDa on SDS/PAGE that matches the expected rDRR1 (recombinant DRR1) molecular mass (18.7 kDa) was obtained. The soluble and insoluble expression of recombinant protein DRR1 (rDRR1) was temperature‐dependent. The expression rDRR1 was in soluble and insoluble forms at 37 °C, and approx. 80% of total rDRR1 was soluble at 37 °C, while rDRR1 was almost exclusively expressing in soluble form at 20 °C. The expressed rDRR1 at 20 °C was affinity‐purified on Ni 2+ ‐charged resin under native conditions. The purified protein was further identified by ESI–MS (electrospray ionization MS). The purified recombinant protein rDRR1 was further used to raise anti‐(human DRR1) polyclonal antibodies, which were suitable for detecting both the recombinant exogenous DRR1 and the endogenous DRR1 from tissues and cells by immunoblotting and immunohistochemistry. The purified rDRR1 and our prepared anti‐(human DRR1) polyclonal antibodies may provide useful tools for future biological function studies on DRR1.